Kurs & Likviditet
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Scandinavian ChemoTech announces that Prashant Agarwal will participate as a top underwriter, with 500 000 SEK, which means he wishes to subscribe in the over-allotment option if the rights issue is fully subscribed.
Prashant has a deep understanding of the healthcare needs in emerging markets and in Europe. He brings a significant network which can benefit ChemoTech's development. Through his holding company Ajna Holding he has interests in Sports, Food Processing and Infrastructure (Engineering, Procurement and Construction), and among them a joint-venture with Serneke International AB, where he also sits as President and CEO. Ajna Holding's subsidiaries are also active in the trading and manufacturing of healthcare products for e.g. the NHS, UKHSC and Indian hospitals.
" I am very pleased to invest in Scandinavian ChemoTech, a company I believe has tremendous global opportunities and being a cancer survivor myself I am committed towards the lager cause of finding a cure or better treatment options for the world." - says Prashant Agarwal
"We are very pleased to have Prashant as one of our new investors, but we are also happy to get the trust from a person with great knowledge of our industry and an enormous network in some of our core markets." - says Mohan Frick CEO and Co-Founder of Scandinavian ChemoTech